Open | $4.780 |
Close | $4.860 |
Volume / Avg. | 34.181K / 18.376K |
Day Range | 4.410 - 5.500 |
52 Wk Range | 4.600 - 44.800 |
Market Cap | $3.394M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 33 |
Short Interest | 56.93% |
Days to Cover | 5.21 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Bio-Path Hldgs (NASDAQ: BPTH) through any online brokerage.
Other companies in Bio-Path Hldgs’s space includes: Tharimmune (NASDAQ:THAR), Synaptogenix (NASDAQ:SNPX), Quoin Pharmaceuticals (NASDAQ:QNRX), Cyclacel Pharmaceuticals (NASDAQ:CYCC) and Geovax Labs (NASDAQ:GOVX).
The latest price target for Bio-Path Hldgs (NASDAQ: BPTH) was reported by HC Wainwright & Co. on Thursday, May 19, 2022. The analyst firm set a price target for 9.00 expecting BPTH to rise to within 12 months (a possible 80.00% upside). 0 analyst firms have reported ratings in the last year.
The stock price for Bio-Path Hldgs (NASDAQ: BPTH) is $5 last updated March 18, 2024 at 4:09 PM EDT.
There are no upcoming dividends for Bio-Path Hldgs.
Bio-Path Hldgs’s Q1 earnings are confirmed for Friday, May 10, 2024.
There is no upcoming split for Bio-Path Hldgs.
Bio-Path Hldgs is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.